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Abstract
In the present work we report the cloning of a full-length cDNA encoding the immediate-early (IE) 2 protein from human herpesvirus
6 (HHV-6) variant A (GS strain). The transcript is 4690 nucleotides long and composed of 5 exons. Translation initiation occurs within the
third exon and proceeds to the end of U86. Kinetic studies indicate that the 5.5-kb IE2 mRNA is expressed under IE condition, within 2–4
h of infection. IE2 transcripts from both variants A and B are expressed under similar kinetics with IE2 transcripts accumulating up to 96 h
postinfection. Although several large transcripts (5.5 kb) hybridized with the IE2 probe, suggesting multiple transcription initiation sites,
a single form of the IE2 protein, in excess of 200 kDa, was detected by Western blot. Within cells, the IE2 protein was detected (8–48 h)
as intranuclear granules while at later time points (72–120 h), the IE2 protein coalesced into a few large immunoreactive patches.
Transfection of cells with an IE2 expression vector (pBK-IE2A) failed to reproduce the patch-like distribution, suggesting that other viral
proteins are necessary for this process to occur. Last, IE2 was found to behave as a promiscuous transcriptional activator. Cotransfection
experiments in T cells indicate that IE2 can induce the transcription of a complex promoter, such as the HIV-LTR, as well as simpler
promoters, whose expression is driven by a unique set of responsive elements (CRE, NFAT, NF-kB). Moreover, minimal promoters having
a single TATA box or no defined eukaryotic regulatory elements were significantly activated by IE2, suggesting that IE2 is likely to play
an important role in initiating the expression of several HHV-6 genes. In all, the work presented represents the first report on the successful
cloning, expression, and functional characterization of the major regulatory IE2 gene/protein of HHV-6.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Human herpesvirus 6 (HHV-6) primary infection in in-
fants is associated with intense fever and often followed by
the development of a maculopapular rash known as exan-
them subitum (Yamanishi et al., 1988). More serious con-
sequences, including meningitis, encephalitis, and hepatitis
have also been reported to occur following HHV-6 infection
(Asano et al., 1990, 1992; Huang et al., 1991; Ishiguro et al.,
1990; Knox et al., 1995). In adults, HHV-6 has been, and is
still considered, a potential cofactor in AIDS disease pro-
gression (for a review see Lusso and Gallo, 1995). One key
factor fueling this hypothesis is the ability of HHV-6 to
modulate HIV-1 infection in vitro (Carrigan et al., 1990; Di
Luca et al., 1991; Ensoli et al., 1989; Geng et al., 1992;
Horvat et al., 1989, 1991; Zhou et al., 1997). Several
genomic segments or open reading frames (ORFs) capable
of efficiently transactivating the HIV-LTR promoter have
been identified (Geng et al., 1992; Gravel et al., 2002;
Horvat et al., 1991; Martin et al., 1991; Nicholas and Mar-
tin, 1994; Zhou et al., 1997).
The HHV-6 linear genome is composed of a large unique
segment (144 kb) flanked by two directly repeated units of
8.7 kb. Within the unique segment are three regions of
repeated sequences termed R1-R3. These repeat regions are
clustered within or around the immediate-early locus A
(IE-A) of HHV-6 which encodes two major IE proteins, IE1
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and IE2. R1 is located within the U86 coding region, R2 lies
between U86 and U89, and R3 is located upstream of the
IE1 gene. R3 (KpnI repeat region), the largest of the repeat
regions, consist of 24–28 segments of 104–107 nucleotides
depending of the HHV-6 variants and isolates (Dominguez
et al., 1999; Gompels et al., 1995; Isegawa et al., 1999).
Within the repeated units of R3, consensus binding sites for
transcription factors such as PEA3, NF-B, and AP-2 were
identified, suggesting that this region may act as potential
cis-acting elements governing the expression of the IE-A
locus (Dominguez et al., 1999; Martin et al., 1991; Thom-
son and Honess, 1992). However, a recent report suggests
that the R3 region acts as a strong enhancer for the expres-
sion of the U95 immediate-early gene in an NF-B-depen-
dent manner (Takemoto et al., 2001). Only a very limited
number of studies on genes encoded from the major IE-A
have been reported. Three studies have detailed the IE1
gene organization for HHV-6 variants A and B and the
relative transactivation ability of the IE1 protein (Gravel et
al., 2002; Martin et al., 1991; Schiewe et al., 1994). The
other major protein encoded within the IE-A locus, the IE2
protein, has yet to be characterized. Genomic sequence
analysis indicates that the HHV-6 U86 is a positional ho-
mologue to the human cytomegalovirus (HCMV) UL122
(Dominguez et al., 1999; Gompels et al., 1995; Isegawa et
al., 1999; Nicholas, 1994). Alignments of the translated
products from HHV-6 U86 and HCMV UL122 indicate that
both protein differ considerably, especially in the first half
of the protein, where no identity can be detected. The
greatest amino acid similarity (44%) is observed in C-
terminal portion of both proteins (Nicholas, 1994). HCMV
UL122 is expressed under IE conditions and encodes an
86-kDa protein, IE86, whose biological functions include
transactivation of heterologous promoters (Hagemeier et al.,
1992; Hermiston et al., 1987; Iwamoto et al., 1990; Klucher
et al., 1993; Lukac et al., 1994), repression of its own
promoter (Chiou et al., 1993; Hermiston et al., 1990; Huang
and Stinski, 1995; Jupp et al., 1993; Liu et al., 1991; Macias
and Stinski, 1993; Pizzorno and Hayward, 1990; Wu et al.,
1993), an association with the viral DNA replication com-
partment (Ahn et al., 1999), and its ability to block cell
cycle progression (Murphy et al., 2000) and modulate apo-
ptosis (Chiou et al., 2001; Zhu et al., 1995). From sequence
analysis and comparison with HCMV, it is hypothesized
that both the IE1 and the IE2 genes of HHV-6 share a
common promoter and a 5 mRNA organization with tran-
scription initiation originating either downstream or up-
stream of the R3 region depending on whether the tran-
scripts have IE or late kinetics of expression, respectively
(Schiewe et al., 1994). To our knowledge, only one article
has reported the protein encoded by U86 as a transcriptional
activator of heterologous promoter (Flamand et al., 1998).
Within the HHV-6 IE2 primary amino acid sequence lie
approximately 48 imperfect repeats of SSRA, SSRD, and
SSKA (R1 region), whose significance and presence with
the IE2 protein remain to be determined (Dominguez et al.,
1999; Gompels et al., 1995; Isegawa et al., 1999; Nicholas,
1994). In the present work we report the cloning of a
complete cDNA sequence encoding HHV-6 IE2 from vari-
ant A (GS strain) and kinetics of mRNA and IE2 protein
expression and provide data on the promiscuous nature of
IE2 in promoting transcriptional activation of promoters
containing several distinct regulatory elements.
Results
Isolation of a full-length IE2 transcript
The HHV-6 linear genome with location of the two IE
loci is presented in Fig. 1A. In addition, details of IE locus
A, with ORFs and repeated regions, are also shown. A
cDNA library from HHV-6 variant A (GS strain)-infected
HSB-2 cells was screened for IE2 mRNA, using a U86
probe. After two screens, a 4690-nucleotide-long transcript
made up of 5 exons was isolated. A diagram of IE2 mRNA
organization and splicing junctions with the corresponding
genomic coordinates referenced according to the HHV-6
U1102 sequence (GenBank X83413) is presented in Fig.
1B. The transcript initiates at position 137285, between U91
and the R3 region, and progresses in the reverse orientation
up to the end of U86. A total of 5 exons make up the mature
mRNA with 4 small exons originating upstream of U89 and
the fifth exon corresponding to U86. Our IE2 cDNA ex-
tends, at the 5 region, by 7 nucleotides the HHV-6 variant
A IE1 transcript previously reported by Schiewe et al.
(1994). Although primer extension is needed to identify the
precise IE2 transcription initiation site, it very likely
matches the IE1 transcription start site (Schiewe et al.,
1994), located 18 nucleotides upstream of our IE2 cDNA
sequence. The 5 regions (exons 1–4) of IE1 and IE2
transcripts are very similar with minor differences likely
attributable to the varying strains of HHV-6 variant A stud-
ied (GS and U1102). A putative TATA box is located at
position 137326, 41 nucleotides upstream of our cloned IE2
transcript. The IE2 coding sequence is contained within
exons 3 to 5 with the first in-frame ATG codon located at
position 136111 in the middle of exon 3 (Fig. 1B). All
introns have typical splicing donor and acceptor sites fol-
lowing the GT . . . AG rule. A polyadenylation signal is
located 21 nucleotides downstream of the stop codon. The
variant A IE2 protein is 1466 amino acids long and has an
estimated molecular weight of 165 kDa with an isoelectric
point of 9.8. Within the carboxy-terminal half of the protein
lays the R1 region, containing a repeated (40 times) tet-
rapeptide sequence (SSRA  SSRD  SSKA  SRKA) as
initially described following partial HHV-6 genomic se-
quence analysis (Nicholas, 1994). Compared to the R1 re-
gion of U1102, the GS R1 region contains an extra 36
nucleotides, translating into an additional three tetrameric-
repeated peptide motif. The IE2 sequence from the GS
strain is 94 and 92% identical to the DNA and amino acid
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sequence of HHV-6 variant A U1102 strain, respectively
(Fig. 1C). The sequence is much more divergent from vari-
ant B, with identities of 85 and 64% at the DNA and amino
acid levels, respectively (Fig. 1C). The IE2 protein from
variant A is 167 amino acids shorter that its counterpart
form variant B, with the largest difference occurring be-
tween amino acids 590 and 616 of variant A IE2 protein.
Kinetics of IE2 mRNA expression
The cloned IE2 cDNA originates within the major IE-A
locus. To analyze the kinetics of IE2 transcription during the
course of an infection, HSB-2 cells were infected with
HHV-6 variant A (GS strain) for varying periods of times,
after which total RNA was extracted and analyzed by
Northern blot using a DNA probe internal to U86. The
results obtained (Fig. 2A) indicate that a transcript of ap-
proximately 5.5 kb could be detected by 4 h of infection.
The intensity of the 5.5-kb IE2 transcript increased gradu-
ally, up to 96 h, at which time the experiment was termi-
nated. At least four additional transcripts of size ranging
between 8 and 15 kb (approximation) with kinetics of ex-
pression similar to that of the 5.5-kb mRNA were detected.
In addition, the 8 to 15-kb transcript intensities are similar
to that of the 5.5-kb message. The 5.5-kb transcript corre-
sponds to our isolated cDNA (4690 nt) plus the poly(A) tail
and a few additional nucleotides in the 5 region. The
structures of the larger transcripts have yet to be determined.
We next studied whether IE2 is expressed under IE
conditions, in the presence of a protein synthesis inhibitor.
HSB-2 cells were treated with cycloheximide (CHX) 30
min prior to and during the 8-h-long infection with HHV-6
variant A and total RNA was extracted and analyzed by
Northern blot. At 8 hours, in the absence of CHX, IE2
expression was weak and a longer film exposure was nec-
essary to detect this transcript (Fig. 2A, right panel). The
IE2 transcript was equally expressed in the absence or in the
presence of CHX, confirming that it belongs to the IE class
of genes. For comparison purpose, we analyzed IE2 tran-
script expression in MOLT-3 cells infected with HHV-6
variant B (Fig. 2B). The kinetics of IE2 mRNA expression
was similar for both variants to IE2 mRNA expression by
2–4 h with increasing expression over time. However, two
major differences were observed. First, in the course of
the variant B infection, the 6.3-kb IE2 message, analo-
gous to the 5.5-kb IE mRNA of variant A, was much more
abundantly expressed relative to the larger IE2 transcripts.
In fact, the 6.3 kb IE2 message was at least three times
more abundantly expressed than any of the larger IE2 tran-
scripts. Second, in the presence of CHX, the 6.3 kb IE2
mRNA accumulated to a much greater level (sixfold) rela-
tive to that of infected and untreated cells (compare Figs. 2A
and B).
Last, the IE2 mRNA expression kinetics was compared
to that of IE1, the other major transcript originating form the
IE-A locus. RNA extracted during the same experiments
presented in Fig. 2A was hybridized with a U89 probe,
specific for the IE1 mRNA. The results obtained (Fig. 2C)
indicate that IE1 is transcribed sooner than IE2 with initial
detection by 2 h of infection. In addition, IE1 mRNA ex-
pression reached near to maximal expression by 12 h, while
IE2 mRNA steadily increased up to 96 h. Interestingly, at
24 h postinfection, a twofold decrease in IE1 mRNA ex-
pression was consistently observed, suggesting that the IE1
gene may be negatively regulated during this period. Sim-
ilar results were observed with variant B (Gravel et al.,
2002). The IE1 mRNA increase at 48–72 h is the likely
result of secondary infections. Finally, IE1 mRNA could
easily be detected in the presence of CHX, with a threefold
greater expression than that observed in infected and un-
treated cells.
Kinetics of HHV-6 IE2 protein expression
To our knowledge, detection of the HHV-6 IE2 protein
has never been documented. Recombinant GST-IE2 protein
is unstable and rapidly degraded in bacteria (data not
shown) and this may explain in part the difficulty in gen-
erating a suitable immunogen for specific anti-IE2 antibody
generation. To alleviate this problem, a branched synthetic
peptide, whose sequence is conserved (14 out of 15 resi-
dues) between both HHV-6 variants, was synthesized and
used to hyperimmunize New Zealand rabbits. Purified anti-
IE2 IgG were first used to detect IE2 protein in HHV-6
variant A-infected HSB-2 cells by immunofluorescence.
The earliest time point at which we could detect IE2 was 8 h
postinfection (Fig. 3A). IE2 was present in the nuclei of
infected cells as small granules whose number varied from
2 to 5. By Days 1 through 3 postinfection, IE2 was found in
a mixture of small and medium-size granules. From Day 4
Fig. 1. (A) HHV-6 genome and details of the major IE locus A. The upper drawing represents the entire HHV-6 genome with the position of the two major
IE loci (IE-A and IE-B) depicted as black rectangles. An asterisk identifies the origin of replication. Below is an enlarged view of the IE locus A and
surroundings with open reading frames represented by arrows. The three major internal repeated regions (R1-R3) are presented as black rectangles. (B)
Mapping of the IE2A transcript and protein sequences. A schematic representation of the full-length IE2 cDNA (GS strain) with genomic coordinates
referenced according to the published HHV-6 (U1102 strain) (GenBank X83413). The IE2 transcript is made up of 5 exons with the first in-frame ATG codon
located at position 136111 in the third exon. The fourth exon is spliced in frame with U86 and ends with a stop codon followed by a poly(A) signal. A line
diagram of the IE2A protein with numbers indicating amino acid position is also presented. (C) Stick diagrams of IE2 protein from HHV-6 variants A and
B. The numbers below the lines represent the amino acid number at the start of individual coding exons. The proteins were aligned for maximal similarity
with gaps (unrelated sequences) drawn as thin lines. The overall nucleotide and amino acid identities, in parenthesis, between IE2 proteins from prototypic
strains from the A variant (GS and U1102) and B variants (Z29 and HST) are also presented.
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Fig. 3. (A) Kinetics of IE2A protein as detected by immunofluorescence. HSB-2 cells were infected with variant A of HHV-6 (GS strain) for varying periods
of time and processed for immunofluorescence using anti-IE2 antibodies as described under Materials and Methods. (B) Kinetics of IE2B protein as detected
by immunofluorescence. Same as in (A) with the exception that MOLT-3 cells were infected with HHV-6 variant B (Z29 strain).
Fig. 2. (A) Kinetics of IE2A mRNA expression. HSB-2 cells were infected with variant A of HHV-6 (GS strain) and total RNA isolated at varying time after
infection was analyzed by Northern blot using a probe corresponding to a fragment of U86. In the right panel, infection was performed in the presence of
CHX for 8 h before Northern blot analysis of IE2 mRNA. IE2 and 18S hybridization signals were determined, normalized, and compared with the 4-h time
point, arbitrarily set at 1. (B) Kinetics of IE2B mRNA expression. MOLT-3 cells were infected with HHV-6 variant B (Z29 strain) and IE2 transcripts detected
as described in (A). IE2 and 18S hybridization signals were determined, normalized, and compared with the 4-h time point, arbitrarily set at 1. (C) Kinetics
of IE1A mRNA expression. HSB-2 cells were infected with variant A of HHV-6 (GS strain) and total RNA isolated at varying time after infection was
analyzed by Northern blot using a probe corresponding to a fragment of U89. Arrows on the side of the figures point to the various transcripts detected. IE1
and 18S hybridization signals were determined, normalized, and compared with the 2-h time point, arbitrarily set at 1.
postinfection and onward, the IE2 granules reached maxi-
mal size with a tendency to fuse into one large patch. By
Day 7 postinfection, the vast majority of infected cells
displayed a single large accumulation of IE2 protein that
occupied up to one-third of the nuclear space. A similar
experiment was conducted using MOLT-3 cells infected
with variant B (Fig. 3B). The overall IE2 distribution fol-
lowed closely that of variant A with IE2 initially (up to Day
1) present as small nuclear dots that eventually fused to-
gether forming an IE2 patch by the second day postinfec-
tion.
Western blot characterization of HHV-6 IE2 protein
The HHV-6 variant A IE2 protein has, in the absence of
posttranslational modifications, a calculated molecular
weight of 165 kDa. Since no published records exist on the
electrophoretic profile of HHV-6 IE2 protein, we proceeded
to analyze the kinetics of IE2 expression by Western blots.
Total protein extracts from uninfected and HHV-6 variant
A-infected HSB-2 cells were electrophoresed and trans-
ferred to a PVDF membrane. The blots were reacted with
the anti-IE2 antibodies and a single protein, with an esti-
mated molecular weight of 220 kDa, could be detected on
the third day postinfection (Fig. 4A). IE2 expression grad-
ually increased up to the fifth day postinfection where it
remained stable up to Day 7. Whether the lower-molecular-
weight proteins reacting with the antibodies represent de-
graded or splice variants of IE2 remains to be determined.
Considering that the smaller IE2 reacting proteins are ob-
served only during late infections, much beyond a single
replicative cycle, when cytopathic effects are pronounced, it
is anticipated that they represent proteolytic cleavage prod-
ucts. For comparative purpose, a similar experiment was
conducted in MOLT-3 cells infected with a B variant of
HHV-6 (Fig. 4B). Much like the results presented in Fig.
4A, a single large IE2 protein of approximately 225 kDa is
detected on the first day postinfection. IE2 expression con-
tinued to increase on the second and third day postinfection.
IE2 is a promiscuous transcriptional activator
The function of HHV-6 IE2 is currently unknown. In a
previous study, we reported that the genomic segment con-
taining U86 could transactivate the CD4 promoter, high-
lighting the possibility that IE2 acts as a transcriptional
modulator (Flamand et al., 1998). To further analyze this
possibility, an expression vector coding for a full-length IE2
from variant A was used to determine the ability of this
protein to transactivate promoters driven by different regu-
latory elements. Before doing so, we first tested whether our
vector, pBK-IE2A, was able to express the IE2 protein.
293T cells were transfected with the pBK control plasmid or
with the pBK-IE2A vector and processed 2 days later for
immunofluorescence assay. Compared to lymphoid cell
lines, 293T cells were transfected with much greater effi-
ciency and were chosen for IE2 detection by immunofluo-
rescence. The results obtained (Fig. 5A) clearly show that
our anti-IE2 antibodies react against a nuclear protein in
pBK-IE2A-transfected cells but are unreactive toward pBK-
transfected control cells. IE2 is diffusely dispersed through-
out the nucleus, in contrast to its dense patchy distribution
in infected cells (Fig. 3).
Having determined that the IE2 protein is expressed
following transfection with the pBK-IE2A vector, we pro-
ceeded to study the ability of this viral protein to activate
various promoter constructs in MOLT-3 T lymphocytes, a
cell type susceptible to HHV-6 infection. The first promoter
studied was the HIV-LTR. Transfection of MOLT-3 cells
with pBK-IE2A led to a dose–response activation of the
HIV-LTR promoter with a maximal activity (18-fold) re-
corded with 4 g of pBK-IE2A vector (Fig. 5B). As control,
cells were transfected with an empty pBK vector whose
activity was arbitrarily set at 1. The DNA quantities were
Fig. 4. (A) Kinetics of IE2A protein as detected by Western blot. HSB-2
cells were infected with HHV-6 variant A (GS strain) for varying periods
of time and IE2 protein detection made by Western blot analysis using
anti-IE2 antibodies as described under Materials and Methods. (B) Kinetics
of IE2B protein as detected by Western blot. Same as in (A) with the
exception that MOLT-3 cells were infected with HHV-6 variant B (Z29
strain).
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kept constant at 12 g by the addition of control pBK
vector. In addition to the HIV-LTR, we generated a reporter
construct containing the HHV-6 IE promoter spanning
554 to82 relative to the transcription start site identified
previously (Schiewe et al., 1994). HHV-6 IE2 also transac-
tivates, in a dose-dependent manner, its own promoter (Fig.
5B). The HIV-LTR and the HHV-6 IE promoters are com-
plex and contain multiple cis-acting regulatory elements
that can influence transcription. To gain a better understand-
ing of the promoter elements responsive to IE2, we used
vectors whose reporter genes are by a single class of tran-
scription factors. These include the CRE-LUC reporter,
driven by the cyclic AMP responsive element binding pro-
teins (CREBs), the pNFAT-LUC plasmid, regulated by the
nuclear factor for activated T-cell (NFAT) proteins, and the
NF-B-LUC reporter, activated by the members of the
NF-B family of proteins. All of these promoters were
significantly activated by IE2. The CRE-LUC and NFAT-
LUC reporter showed the strongest activation with a 20-fold
activation relative to the pBK control vector. A 4-fold ac-
tivation of the NF-B-LUC reporter was observed with 4
g of pBK-IE2A effector plasmid. In most cases, the 8 g
dose of pBK-IE2A caused a reduction in promoter activity,
suggesting that in MOLT-3 cells maximal activation is
reached with effector plasmid doses ranging between 4 and
8 g. Last, we studied the ability of IE2A to activate
minimal promoters. The promoters studied include the
pTATA-LUC with a TATA box as the only recognizable
regulatory element and the pGL3 basic plasmid, which lacks
typical eukaryotic promoter regulatory elements. Once
again, cotransfection of pBK-IE2A with the two minimal
promoter constructs led to a dose–response activation of the
luciferase reporter gene. To confirm that the transactivation
by IE2 is real and does not simply reflects an increase in
transfection efficiency, were carried out experiments in
which MOLT-3 cells were cotransfected with a constant
amount of GFP-expressing vector (4 g) along with varying
quantities (0–8 g) of pBK-IE2. DNA levels were brought
up to 12 g by the addition of empty pBK vector. Forty-
eight hours postelectroporation, MOLT-3 cells were ana-
lyzed by flow cytometry and the number of GFP cells was
determined. The results (last graph of Fig. 5B) indicate that
at 0, 2, and 4 g of pBK-IE2A, the number of GFP cells
was similar, indicating that transfection efficiencies were
roughly equal. However, cells transfected with 8 g of
pBK-IE2A were found to consistently have a reduced num-
ber of GFP cells. Considering that the total DNA quanti-
ties are identical (12 g) in each samples, this effect is
likely attributable to IE2. One possibility is that HHV-6 IE2
causes a cell cycle blockade, preventing the transfected cells
to divide in a manner analogous to that reported by the
HCMV IE2 protein (Murphy et al., 2000). Current work is
in progress to address this issue. In summary, these results
indicate that the IE2A protein of HHV-6 is capable of
activating multiple promoters having no regulatory ele-
ments in common, suggesting that IE2A likely modulates
transcription through interaction with the basic cellular tran-
scription machinery.
Discussion
The major IE locus A of HHV-6 contains two large
ORFs, U89 and U86, coding in part for the IE1 and IE2
proteins, respectively. We recently reported on the charac-
terization of HHV-6 variant B IE1 transcript and protein
(Gravel et al., 2002). In the present article we report the
cloning of a complete IE2 cDNA and transcript organization
and provide data on the kinetics of expression and the
biological activities of the IE2 protein from HHV-6 variant
A. The mature IE2 mRNA 5 region is essentially identical
to the 5 end of the IE1 mRNA previously described
(Schiewe et al., 1994). In fact, the first 4 small exons are the
same with minor sequence variations attributable to the
differing HHV-6 A variant isolates studied (GS versus
U1102). For both IE1 and IE2, translation is presumed to
initiate in the middle of exon 3. In the IE2 mRNA, the splice
donor site of exon 4 is identical to that of the IE1 transcript
and joins, in-frame, a splice acceptor site located 47 nucle-
otides upstream of the first ATG codon of ORF U86. The
Fig. 5. (A) Transfection of 293T cells with pBK-IE2A expression vector.
293T cells were transfected with an expression vector for IE2A (pBK-
IE2A) and processed for immunofluorescence using an IE2 rabbit anti-
serum. (B) IE2 acts as promiscuous transcriptional activator. MOLT-3 T
cells were electroporated with various luciferase reporter plasmids (4 g)
and varying quantities (2–8 g) of pBK-IE2A expression vector. The
plasmid DNA levels were kept constant at 12 g for each condition by the
addition of empty pBK vector. The 0-g value, arbitrarily set at 1, repre-
sents cells transfected with the reporter plasmid (4 g) and 8 g of pBK
control vector. The data represent the normalized mean  standard devi-
ation (SD) (in fold induction) of three independent experiments performed
in duplicate. The bottom right graph represents MOLT-3 transfection
efficiencies in relation to increasing doses of pBK-IE2A. A GFP expression
vector (4 g) was cotransfected with 0, 2, 4, or 8 g of pBK-IE2 vector.
DNA levels were kept constant at 12 g by the addition of empty pBK
vector. Forty-eight hours after electroporation, cells were analyzed for GFP
expression by flow cytometry. Transfection efficiencies were computed
relative the pBK-IE2A 0 g values, arbitrarily set at 100%. Results rep-
resent the mean  SD of three independent transfection experiments.
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IE2 transcript includes all of U86 and terminates with a
poly(A) signal. In terms of expression, the 5.5-kb IE2 tran-
script can be detected in the presence of CHX, confirming
its expression under IE kinetics. IE2 mRNA is expressed
after the IE1 message and continues to accumulate through-
out the infectious cycle in contrast to IE1 mRNA, which
remains constant after 12 h of infection. Both HHV-6 vari-
ants A and B had similar IE2 kinetics. Large transcripts
hybridizing with the IE2 probe accumulated during late-
stage infection, suggesting multiple transcription initiation
sites as previously proposed for the IE1 transcripts (Schiewe
et al., 1994). It is worth noting that the abundance of the
larger IE2 transcripts, relative to the 5.5- and 6.3-kb IE2
mRNAs from variants A and B, respectively, differ consid-
erably. In the case of variant A, the larger IE2 transcripts
accumulated with kinetics and abundance similar to those of
the 5.5-kb IE2 mRNA. For variant B, IE2 expression was
heavily skewed in favor of the 6.3-kb transcript, suggesting
that transcriptional regulation of IE2 mRNAs differ between
HHV-6 variants. Interestingly, a recent article reported the
U86 ORF to be part of latency-associated transcripts in
HHV-6 variant B-infected monocytes (Kondo et al., 2002).
Such transcripts were present as two distinct species. Type
II transcript originated between exons 2 and 3 of the pro-
ductive infection IE2 transcription start site while type I
initiated 9.8 kb upstream of the productive IE2 transcript
(Kondo et al., 2002, and present study). IE2 protein is
apparently not translated from these latency-associated tran-
scripts, suggesting that viral replication may be suppressed
at the point of the translation of major IE proteins during
latency (Kondo et al., 2002). These HHV-6 latency-associ-
ated transcripts were present during the productive phase of
infection, albeit at very low levels, minimizing their poten-
tial roles during productive infection.
Protein sequence analysis indicates that the IE2 protein is
approximately 165 kDa in size and contains several putative
PKC and CaKII phosphorylation sites, suggesting that IE2
may be a phosphoprotein. HHV-6 IE2 protein shares limited
amino acid similarities with the HCMV IE2 protein. Trans-
lated sequence analysis indicates that the R1 region, com-
posed of 46 imperfect tetrameric amino acid repeated motifs
(SSRA [31], SSRD [8], SSKA [5], SSRT [1], SSRE [1]), is
present within the variant A (GS strain) IE2 protein. For
comparison, the R1 region from the Z29 B variant contains
48 tetrameric repeated motifs, 42 of which have the SSRA
sequence. The functional significance of these reiterated
sequences remains undetermined. In terms of protein, infec-
tion of cells by both HHV-6 variants led to the detection of
a single specie of IE2 having a molecular mass in excess of
200 kDa. This result is somewhat different than that ob-
served during HCMV infection where spliced variants of
IE2 are produced (Stenberg et al., 1985). Within infected
cells, HHV-6 IE2 was first detected as intranuclear granules,
which coalesced into a single large immunoreactive patch
by 72 h postinfection. These IE2 patches are reminiscent of
the HCMV IE2 patches observed in infected cells (Ahn et
al., 1999). HCMV IE2 is known to be required for efficient
viral DNA replication and to be associated with the viral
replication compartments. Work is in progress to address
whether HHV-6 IE2, in a manner analogous to HCMV IE2,
is associated with the viral DNA replication complex. A
basic isoelectric point of 9.8 for HHV-6 IE2 is consistent
with a potential for this protein to interact with DNA. IE2
expression, in the absence of any other HHV-6 proteins was
observed as a diffuse nuclear staining. Thus, the inability to
reproduce the patchy appearance observed during late-stage
infection is likely attributable to the failure in recruiting
viral factors, such as polymerase processivity factor (U27)
and the single-stranded DNA binding protein (U41), for the
generation of functional replication DNA compartment.
It is currently unknown whether HHV-6 IE2 can nega-
tively regulate its own expression in a manner similar to that
of HCMV IE2 (Cherrington et al., 1991; Liu et al., 1991;
Pizzorno and Hayward, 1990). HCMV IE2 is reported to
bind to a cis repression signal (crs) located between that
TATA box and the transcription start site (Lang and Stam-
minger, 1993, 1994; Macias and Stinski, 1993). This crs site
overlaps an initiator sequence (Carcamo et al., 1991; Java-
hery et al., 1994; Smale and Baltimore, 1989). Interestingly,
such an initiator sequence (Py Py A N T/A Py Py) is present
adjacent to the transcription start site (10 to 4) of
HHV-6 IE genes and whether HHV-6 IE2 protein interacts
with this region to negatively modulate its own expression
remains to be determined. Our IE2 mRNA kinetics data
indicate that IE2 expression continues to increase with time
and does not appear to be turned off, even at times when
large quantities of IE2 protein are detected. This suggests
that IE2 does not appear to directly suppress its own tran-
scription. Our transactivation assay results using the HHV-6
IE promoter (554 to 82), which indicate that IE2 acti-
vates its own promoter (Fig. 5B), are in support of such
affirmation.
The IE2 promoter/enhancer has yet to be fully charac-
terized. A study from Schiewe et al. (1994) has mapped the
transcription start site of the IE1 gene, which more than
likely is the same for the IE2 gene, 27 nucleotides down-
stream of the TATA box. It has been speculated that the R3
region could function as an enhancer for MIE genes
(Dominguez et al., 1999; Martin et al., 1991; Thomson and
Honess, 1992). The R3 region consists of 24 copies of
repeated 104- to 107-bp units with abundant binding sites
for cellular transcription factors (AP-2, NF-B, PEA3). A
recent report indicates that the R3 region plays an important
role for U95 gene expression, an IE gene located down-
stream of the R3 region in orientation opposite the IE2 gene
(Takemoto et al., 2001). Whether the R3 region plays a role
in the regulation of HHV-6 IE2 gene expression remains to
be determined.
One common feature of HHV-6 and HCMV IE2 proteins
is their ability to promiscuously transactivate heterologous
promoters. So far, HHV-6 IE2 transactivated all promoters
tested. These include complex promoters such as HIV-LTR,
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HHV-6 IE, and more simple promoters driven by unique
responsive elements (NFAT, NF-B, CRE), or a minimal
promoter containing only a TATA box. The ability of IE2 to
activate multiple promoters having no regulatory element in
common suggests that IE2 can interact with basic cellular
machinery and positively modulates transcription. This is
not unique to HHV-6, as several viruses rely on host factors
to govern the expression of their genes. In fact, HCMV IE2
is reported to interact with host factors such as TFIIB,
TFIID, P/CAF, and CBP, all of which lead to the transcrip-
tional activation of specific HCMV-responsive elements.
(Bryant et al., 2000; Caswell et al., 1993; Schwartz et al.,
1996; Sommer et al., 1994). Our current difficulties in
expressing full-length IE2 in bacteria or immunoprecipitat-
ing this viral protein from infected or transfected cells have
so far prevented us from studying the physical interactions
between IE2 and cellular transcription factors.
The results presented in this article represent the first
molecular and biological characterization of the IE2 protein
of HHV-6. Considering that the major IE locus A is among
the most divergent region between variants, a thorough
comparative analysis is warranted to determine whether
some of the differing biological properties among variants
could be ascribed to differences in IE2 proteins functional-
ities. The IE2 transactivator likely plays a crucial role in the
regulation of HHV-6 gene expression and the importance of
this protein in the replicative cycle awaits the generation of
specific IE2 mutants of HHV-6.
Materials and methods
Cell culture and virus preparation
The HSB-2 and MOLT-3 cell lines were maintained in
RPMI 1640 medium supplemented with 10% fetal bovine
serum (Sigma–Aldrich Canada, Oakville, Ontario) and M-
plasmocin (InvivoGen, San Diego, CA) to prevent myco-
plasma contamination. The 293T cell line was cultured in
Dulbecco’s modified Eagle medium (DMEM; Sigma) sup-
plemented with 10% fetal bovine serum and M-plasmocin.
The GS strain of HHV-6A was propagated on HSB-2 cells
and the Z29 strain of HHV-6B, on MOLT-3 cells, as pre-
viously described (Gravel et al., 2002). The infectivity titer
of both viruses was determined after 24 h of infection with
various dilutions of HHV-6, by immunofluorescence. In-
fected cells were fixed in acetone for 10 min at 20°C,
air-dried, and incubated with Alexa 488-labeled anti-IE1
antibodies for 1 h at room temperature. Three 5-min PBS
washes were done before slides were mounted with glycerol
and examined under a fluorescent Leitz Aristoplan micro-
scope (Leica, Richmond Hill, Canada). The HHV-6 titers
were then determined by calculating the percentage of IE1-
positive cells. The HHV-6A titer was determined to be 2 
107 infectious particles per milliliter, while the HHV-6B
titer was 6  106 infectious particles per milliliter.
cDNA library construction, screening, and sequencing
To obtain a cDNA library representative of the majority
of HHV-6 transcripts, RNA was isolated from HSB-2 cells
infected with HHV-6 variant A under three different con-
ditions: under IE condition using a 7-h infection in the
presence of 10 g/ml CHX, under early condition using a
2-day infection in the presence of 100 g/ml phosphono-
acetic acid (PAA), and under late condition using a 3-day
infection in the absence of inhibitors. Total RNA was iso-
lated using the Trizol reagent (Invitrogen, Burlington, On-
tario), mRNA was obtained using the poly(A) Tract kit
(Promega, Madison, WI), and a  ZAP express cDNA
library was constructed according to the manufacturer’s
guidelines (Stratagene, La Jolla, CA). A 1.8 kb EcoRI
fragment obtained from the central part of the U86 gene
from HHV-6A, strain U1102, was used to screen the cDNA
library. A full-length IE2A was obtained after two succes-
sive rounds of hybridization with the U86 fragment. The
transcript was completely sequenced on one strand using an
automated ABI Prism sequencer (Perkin–Elmer, Boston,
MA). Sequence analyses of IE2 from different variants and
isolates of HHV-6 were performed using BLAST programs
(Altschul et al., 1990, 1997).
Kinetics of IE1 and IE2 mRNA expression in HHV-6-
infected cells
HSB-2 cells were infected with HHV-6A (GS strain) for
2 to 96 h, at a MOI of 0.1. At indicated times, total RNA
was isolated from 10  106 cells using the Trizol reagent.
Total RNA was also isolated from 10  106 cells infected
with HHV-6A for 8 h in the presence of 10 g/ml cyclo-
heximide, to determine the presence of IE1 and IE2 genes
under IE conditions. Ten micrograms of total RNA was
migrated on a 1% agarose–formaldehyde gel, transferred
onto nylon membranes, and probed for IE1 and IE2 genes,
as previously described (Gravel et al., 2002). Membranes
were probed for the presence of the IE1 gene using a
KpnI–BglII fragment from the U89 region of HHV-6A
(U1102 strain), while membranes were probed for the pres-
ence of IE2 gene using a EcoRI fragment derived from the
U86 region of HHV-6A (U1102 strain). MOLT-3 cells were
infected with HHV-6B (Z29 strain) for different periods of
time, as previously described (Gravel et al., 2002).
Anti-IE2 antibody generation
A branched peptide of 15 amino acids (IESSYRESRN-
TNRGY) having 93% identity between both HHV-6 vari-
ants was synthesized using the FastMoc chemistry. The
purified peptide, directed against the N-terminal part of the
full-length IE2 protein (GS strain: amino acids 212–226),
was resuspended in PBS. One milligram of peptides was
emulsified in complete Freund’s adjuvant and injected in-
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tramuscularly into New Zealand rabbits. After seven immu-
nizations, rabbits were bled by cardiac puncture and IgG
immunoglobulins were purified using a HiTrap Protein G
Sepharose HP affinity column (Amersham Biosciences,
Baie d’Urfe´, Quebec). Anti-peptide IgG was labeled using
the Alexa-Fluor 488 protein labeling kit for fluorescence
analysis (Molecular Probes, Eugene, OR, USA).
Kinetics of IE2 protein expression in HHV-6-infected cells
HSB-2 cells were infected with HHV-6A (GS strain) at
a MOI of 0.03 for periods of time ranging from 4 h to 7 days
and MOLT-3 cells were infected with HHV-6B (Z29 strain)
at a MOI of 0.02 for 12 h to 3 days. At indicated times, 3 
106 cells were prepared for immunofluorescence (IFA) and
10  106 cells were prepared for western blot analysis. For
IFA, cells were washed twice in PBS before 1.5  105
cells/well were deposited onto 10-well microscope glass
slides (ICN Pharmaceuticals, Costa Mesa, CA). When dry,
they were fixed in cold acetone (20°C) for 10 min. The
slides were then incubated with HHV-6 Alexa 488-labeled
rabbit anti-IE2 antibody in PBS for 1 h at room temperature.
Slides were washed three times in PBS, mounted with
glycerol/PBS before examination, and photographed on a
fluorescent Leitz Aristoplan microscope using a Dage MTI
black and white cooled camera (8 bits) and Bioquant True
Color Windows 98 software (R&M Biometrics, Inc., Nash-
ville, TN). For Western blot analysis, cells were washed in
PBS and lysed in 1 ml of lysis buffer for 30 min on ice, as
described (Gravel et al., 2002). Samples were sonicated
briefly and centrifuged at 18,000g for 10 min. Soluble
proteins from the supernatants were electrophoresed
through a 6% SDS–PAG, transferred to polyvinylidene flu-
oride (PVDF) membranes, and blotted for HHV-6 IE2 pro-
tein using a rabbit anti-IE2 antibody for 1 h at room tem-
perature. After three 10-min washes with TBST, the blots
were incubated with horseradish peroxidase-conjugated
goat anti-rabbit IgG antibodies for 1 h. The blots were
washed with TBST and the proteins were visualized with
enhanced chemiluminescence (Perkin–Elmer) using a Phos-
phorImager system (Fuji Medical Systems, Stamford, CT).
Transient DNA transfection of 293T cells
293T cells were seeded into six-well plates at 3  105
cells per well the day before transfection. Cells were trans-
fected with 2 g of pBK control vector or pBK-HHV-6
IE2A expression vector using the ExGen transfection re-
agent (MBI Fermentas, Flamborough, Ontario). Forty-eight
hours posttransfection, cells were trypsinized, washed three
times in PBS, and 3.5  105 cells per well were deposited
onto 10-well microscope glass slides and processed for
immunofluorescence as described above.
Luciferase reporter assay
Two, four, or eight micrograms of pBK-HHV-6 IE2A
expression plasmid was cotransfected with 4 g of different
luciferase reporter plasmids in 1  107 MOLT-3 cells by
electroporation (250 V, 960 Fd). The DNA levels were
kept constant at 12 g by the addition of empty pBK vector.
The cells were harvested 2 days after transfection, resus-
pended in 0.2 ml of cell lysis buffer (Promega), and incu-
bated at room temperature for 30 min with gentle agitation.
Aliquots of 20 l were analyzed for the luciferase activity
using a MLX luminometer (Dynex Technologies, Chantilly,
VA). Protein quantities were assessed for all samples and
luciferase activity recorded was normalized accordingly.
Nucleotide sequence accession number
The sequence described in this article has been deposited
under GenBank Accession No. AY037931.
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